Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Dermatologic 1

Conditions

Melanoma 36Neoplasm Metastasis 12Carcinoma, Renal Cell 11Carcinoma, Non-Small-Cell Lung 11Lung Neoplasms 10Colorectal Neoplasms 7Carcinoma, Hepatocellular 7Carcinoma, Merkel Cell 6Uterine Cervical Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Ovarian Neoplasms 5Carcinoma, Basal Cell 5Lymphoma, T-Cell, Cutaneous 4Lymphoma, T-Cell 4Endometrial Neoplasms 4Carcinoma, Transitional Cell 4Uveal Melanoma 3Triple Negative Breast Neoplasms 3Thyroid Neoplasms 3Small Cell Lung Carcinoma 3Sarcoma, Kaposi 3Prostatic Neoplasms 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Esophageal Neoplasms 3Carcinosarcoma 3Breast Neoplasms 3Stomach Neoplasms 2Skin Neoplasms 2Sarcoma 2

Interventions

Transdermal Patch 1Spinal Puncture 1Spectrum Analysis, Raman 1Specimen Handling 1Nivolumab 1Mass Screening 1Magnetic Resonance Spectroscopy 1Genome 1Diagnostic Imaging 1Dermoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nevus × Specimen Handling × Dermatologic × Clear all
NCT03025256 2026-05-05

Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease

M.D. Anderson Cancer Center

Phase 1 Recruiting
75 enrolled
DermatologicThoracic

Uveal Melanoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Melanoma, Meningeal Neoplasms, Nevus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡